Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | +1.50% | +6.93% | +8.00% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 35.55M | |
+8.64% | 105B | |
-0.90% | 104B | |
+5.44% | 22.94B | |
-12.25% | 22.34B | |
-6.31% | 19.25B | |
-39.98% | 17.08B | |
-8.69% | 16.96B | |
+7.59% | 14.16B | |
+38.96% | 12.63B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Piper Sandler Adjusts OncoCyte's Price Target to $1.80 from $3.10, Keeps Overweight Rating